News

The FDA will evaluate the BLA for an indication of managing preoperative or bleeding patients who require replacement of multiple plasma coagulation factors, the company said. The BLA

The company has begun negotiations for the manufacturing and national distribution of this new product line. The negotiations will actively continue when the first prototypes are received by

iNO is available as Inomax (nitric oxide) for inhalation, that selectively relaxes the cells of the pulmonary vasculature, resulting in increased blood flow through the lungs and delivery

The companies will collaborate to integrate the technology into viral clearance services provided by Charles River, which is designed to result in a consistent study outcome for clients.

The companies will develop disease models using diverse biologic data to elaborate disease-relevant mechanisms and find out potential new drug discovery opportunities. Selventa will leverage molecular patient data

Alacer produces nearly 500m packets of Emergen-C annually, and its products are sold in health food stores, supermarkets, drug stores, mass merchandisers and club stores. Emergen-C is an

The organic herbal lozenge is packed with a blend of organic herbal extracts nettle, eyebright, elderflower, plantain, vitamin C, and menthol. The company recommends the herbal product to

Sandoz Canada has stopped production at its plant in Quebec after the US Food and Drug Administration raised safety and reliability issues at the facility. Health Shared Services

The public entity has remained closed since 2011 after it incurred massive losses, the The Himalayan Times reported. The company had reported a cumulative loss of NPR485.85m ($6.64m)